343 related articles for article (PubMed ID: 15996700)
1. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
Snow ET; Sykora P; Durham TR; Klein CB
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
[TBL] [Abstract][Full Text] [Related]
2. Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite.
Sykora P; Snow ET
Toxicol Appl Pharmacol; 2008 May; 228(3):385-94. PubMed ID: 18252256
[TBL] [Abstract][Full Text] [Related]
3. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
Kitchin KT; Conolly R
Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
[TBL] [Abstract][Full Text] [Related]
4. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
[TBL] [Abstract][Full Text] [Related]
5. Implications of arsenic genotoxicity for dose response of carcinogenic effects.
Rudel R; Slayton TM; Beck BD
Regul Toxicol Pharmacol; 1996 Apr; 23(2):87-105. PubMed ID: 8661328
[TBL] [Abstract][Full Text] [Related]
6. Arsenic toxicity at low doses: epidemiological and mode of action considerations.
Schoen A; Beck B; Sharma R; Dubé E
Toxicol Appl Pharmacol; 2004 Aug; 198(3):253-67. PubMed ID: 15276404
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
Kitchin KT
Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic changes induced by chronic low dose exposure to arsenic of mouse testicular Leydig cells.
Singh KP; DuMond JW
Int J Oncol; 2007 Jan; 30(1):253-60. PubMed ID: 17143536
[TBL] [Abstract][Full Text] [Related]
9. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
10. [Effect of selenium and arsenic on oxidative stress, DNA oxidative damage and repair in HepG2 cells].
Lai R; Wang Y; Li X; Yu RA
Wei Sheng Yan Jiu; 2008 Nov; 37(6):645-8. PubMed ID: 19238993
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.
Sen B; Wang A; Hester SD; Robertson JL; Wolf DC
Toxicology; 2005 Nov; 215(3):214-26. PubMed ID: 16122865
[TBL] [Abstract][Full Text] [Related]
12. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity.
Gentry PR; McDonald TB; Sullivan DE; Shipp AM; Yager JW; Clewell HJ
Environ Mol Mutagen; 2010 Jan; 51(1):1-14. PubMed ID: 19551812
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid.
Chilakapati J; Wallace K; Ren H; Fricke M; Bailey K; Ward W; Creed J; Kitchin K
Toxicology; 2010 Jan; 268(1-2):31-9. PubMed ID: 19945496
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
16. The role of oxidative stress in hormesis induced by sodium arsenite in human embryo lung fibroblast (HELF) cellular proliferation model.
Yang P; He XQ; Peng L; Li AP; Wang XR; Zhou JW; Liu QZ
J Toxicol Environ Health A; 2007 Jun; 70(11):976-83. PubMed ID: 17479414
[TBL] [Abstract][Full Text] [Related]
17. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
18. Comparative investigations of sodium arsenite, arsenic trioxide and cadmium sulphate in combination with gamma-radiation on apoptosis, micronuclei induction and DNA damage in a human lymphoblastoid cell line.
Hornhardt S; Gomolka M; Walsh L; Jung T
Mutat Res; 2006 Aug; 600(1-2):165-76. PubMed ID: 16764896
[TBL] [Abstract][Full Text] [Related]
19. Arsenic-induced bladder cancer in an animal model.
Cohen SM; Ohnishi T; Arnold LL; Le XC
Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
[TBL] [Abstract][Full Text] [Related]
20. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
